Page last updated: 2024-09-05

sorafenib and tiopronin

sorafenib has been researched along with tiopronin in 2 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(tiopronin)
Trials
(tiopronin)
Recent Studies (post-2010) (tiopronin)
6,5207305,25191232107

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)tiopronin (IC50)
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)1.9

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Guo, W; Li, J; Qiu, X; Yan, B; Zhang, S1

Reviews

1 review(s) available for sorafenib and tiopronin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for sorafenib and tiopronin

ArticleYear
Prospective analysis of tiopronin in prevention of sorafenib and antiviral therapy inducing liver toxicity in advanced hepatitis B virus-related hepatocellular carcinoma.
    Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:10

    Topics: Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Sorafenib; Tiopronin

2015